Apr 12, 2026
•
15 min read
Plus: an AI that reads heart fat predicts failure five years out, Medra opens America's largest autonomous lab, and Genentech tests AI agents on 100 biology tasks.
Apr 10, 2026
13 min read
Amy Webb's Convergence Outlook devotes two of ten convergences to AI × bio. I read the 40+ pages so you don't have to.
Apr 9, 2026
12 min read
Plus: An AI designed enzymes for chemistry nature never invented, and a new study shows AlphaFold reversed a long-running decline in scientific novelty.
Apr 5, 2026
Plus: A massive AI model predicts aging and a paper says AI can replace biological clocks.
Apr 2, 2026
9 min read
A Johns Hopkins professor says AI in biology is starting to look like pseudoscience. Here's what covering 60+ stories in the past six weeks have taught us.
14 min read
Plus: three ex-Ginkgo leaders argue biology needs its Bauhaus moment, and the LabOS team builds a simulation universe for AI agents.
Mar 30, 2026
Plus: Meta open-sources a digital model of the brain, an AlphaFold veteran's agent designs drugs from a text prompt, and Anthropic may be building a biology mode.
Mar 25, 2026
Plus: A $787 million AI biologics company emerges, and a multi-agent AI for dementia validated across 3 million patients.
Mar 22, 2026
Plus: The field's own reality check, and experts preferred BioReason-Pro's reasoning over curated databases.
Mar 18, 2026
16 min read
Plus: NVIDIA breaks the size ceiling on protein folding, a million AI-designed proteins get tested in actual wet labs, and OpenClaw gets a science layer.